Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Reata Pharma (NQ: RETA )

88.47 -1.23 (-1.38%)
Streaming Delayed Price Updated: 11:14 AM EDT, May 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Reata Pharma

< Previous 1 2 3 4 5 6 7 Next >
Abercrombie & Fitch, Urban Outfitters, Photronics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Reata Pharmaceuticals Stock Plummets More Than 20%: Here's Why
Reata Pharmaceuticals Inc (NASDAQ: RETA) and its partner Kyowa Kirin Co Ltd have decided to discontinue  
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Reata Pharma Tumbles After Scrapping Its Kidney Drug As Earnings Come In Mixed
Reata scrapped development of bardoxolone in chronic kidney disease. 
Via Investor's Business Daily
Recap: Reata Pharmaceuticals Q1 Earnings
 
Via Benzinga
Earnings Outlook For Reata Pharmaceuticals
 
Via Benzinga
Where Reata Pharmaceuticals Stands With Analysts
 
Via Benzinga
Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! 
Via InvestorPlace
Where Reata Pharmaceuticals Stands With Analysts
 
Via Benzinga
2 Top Healthcare Stocks Defying the Bear Market
These two healthcare stocks have been swimming against the current. 
Via The Motley Fool
Why Reata Pharmaceuticals Stock Skyrocketed This Week
A major regulatory approval lit a fire underneath Reata's shares this week. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
3 Stocks That Already Doubled in 2023 and Could Keep Climbing
The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run. 
Via The Motley Fool
The 3 Best Growth Stocks to Buy in the Biotech Sector
These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. 
Via InvestorPlace
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing
The high-flyers have soared to new heights and further gains could be up ahead. 
Via The Motley Fool
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
Many leaders flashed buy signals as the indexes rebounded from support. 
Via Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this... 
Via Benzinga
Why Is Reata Pharmaceuticals Stock Trading Higher Today?
Reata Pharmaceuticals (NASDAQ: RETA) shares are trading higher on Wednesday after the company announced the FDA approved SKYCLARYS for the treatment of Friedreich's ataxia. 
Via Benzinga
Nasdaq Down 75 Points; B&G Foods Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 75 points on Wednesday. The Dow traded down 0.19% to 32,596.21 while the NASDAQ fell 0.66% to 11,379. The... 
Via Benzinga
Dow Looking To Rebound After Rocky February
The Dow Jones Industrial Average is up 81 points this afternoon, while the S&P 500 Index and Nasdaq Composite are lower, with stocks kicking off a new month after a February decline. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga
Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia. 
Via Benzinga
Dow Edges Higher; ISM Manufacturing PMI Rises In February
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday. The Dow traded up 0.12% to 32,695.97 while the NASDAQ fell 0.23% to 11,429.16. The S&P 500... 
Via Benzinga
3D Systems, CarGurus, Sarepta Therapeutics And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
US Stocks Edge Lower; Dollar Tree Profit Beats Views
U.S. stocks traded slightly lower this morning, with the Nasdaq Composite dropping around 30 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.09% to 32,626.82 while... 
Via Benzinga
Reata Pharmaceuticals Gets Price Target Bumps By Analysts Following FDA Approval Of Skyclarys
Reata Pharmaceuticals Inc (NASDAQ: RETA) reported the FDA approval of SKYCLARYS for patients with Friedreich's ataxia. With this approval, the FDA granted a rare pediatric disease priority review... 
Via Benzinga
Investors Just Hit the Jackpot on These 2 Nasdaq Biotech Stocks
Markets are trying to rise, and these companies are helping out. 
Via The Motley Fool
Why Is Novavax (NVAX) Stock Down 26% Today?
Novavax (NVAX) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.